Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 25, 2017 09:30 ET | Source: Blake Insomnia Therapeutics, Inc.

Blake Insomnia Therapeutics Inc. Announces Submitting Clinical Trial Application for Phase II Clinical Testing

NEW YORK, Aug. 25, 2017 (GLOBE NEWSWIRE) -- Blake Insomnia Therapeutics Inc. (OTCQB:BKIT), a New York based pharmaceutical company devoted to improving quality of life for people with insomnia, is...
May 09, 2017 13:20 ET | Source: Blake Insomnia Therapeutics, Inc.

Blake Insomnia Therapeutics Inc. Announces Appointment of Dr. Eric Leire to its Board of Directors

NEW YORK, May 09, 2017 (GLOBE NEWSWIRE) -- Blake Insomnia Therapeutics Inc. (OTCQB:BKIT) a New York based pharmaceutical company is pleased to announce the appointment of Dr. Eric Leire to join CEO...
February 24, 2017 20:08 ET | Source: Blake Insomnia Therapeutics, Inc.

Blake Insomnia Therapeutics Inc. Closes Joint Venture with Sajo Consulting LLC

NEW YORK, Feb. 25, 2017 (GLOBE NEWSWIRE) -- Blake Insomnia Therapeutics Inc. (OTCQB:BKIT) and Sajo Consulting LLC are pleased to announce completion of a joint venture agreement for the development...
January 17, 2017 08:30 ET | Source: Blake Insomnia Therapeutics, Inc.

Blake Insomnia Therapeutics Inc. Seeks Financing for Clinical Trials

NEW YORK, Jan. 17, 2017 (GLOBE NEWSWIRE) -- Blake Insomnia Therapeutics Inc. (OTC:BKIT) is preparing to launch a fundraising drive to complete Phase II clinical testing of its patent-pending ZLX-1...